RRM2 and non-small cell lung carcinoma: We investigated the effect of the expression of seven biomarkers (ERCC1, BRAC1, RRM1, RRM2, P53R2, TUBB3, and TS) on survival in stages I–III NSCLC patients treated with surgery alone.